Odisha STF Arrests One More Accused In Fake Covid Drugs Case

Bhubaneswar: The Special Task Force (STF) of the Odisha Crime Branch has arrested one more accused on charges of procuring and selling fake medicines, especially medicines used in the treatment of Covid-19.

STF has arrested the Managing Director of “Medilloyd Medicament Private Limited” and forwarded him to Court. STF had yesterday arrested three accused persons, including one Director and two key members of the company, in this case. With this, four persons have been arrested so far.

Reportedly, the STF had launched an investigation on the report of Drug Officials of Cuttack alleging circulation of fake medicines, especially medicines used in the treatment of Covid-19 i.e. FAVIMAX-200 and FAVIMAX-400 (Favipiravir).

Multiple teams had been formed to conduct a thorough investigation, including conducting raids, studying the documents, linkages/ networking in other states, modus operandi, etc. Currently, three teams are conducting investigations in Odisha, Maharashtra, and West Bengal.

During the course of investigation till date, it came to light that Max Relief Health Care is a dubious drug manufacturing company claiming to be manufacturing drugs in Solan, Himachal Pradesh. This dubious company was run by two persons. Both of them have been arrested by Mumbai Police earlier this month. It is also learnt that cases have been registered against these two in other states too.

Investigations by STF so far revealed that “Medilloyd Medicament Private Limited” conspired to procure Favimax tablets from “Max Relief Health Care” at a very low price (Rs 65/- per strip of 10 tablets) and had planned to sell them at a very high price (Rs 1290/- per strip of 10 tablets).

Yesterday, STF arrested three accused persons in this case. Further, STF has also located and frozen more than Rs 50 lakh in the bank accounts of the accused and the above company. Further investigation is on by multiple teams of STF in Odisha, Maharashtra, and West Bengal.

Abhay, DGP, Odisha